Skadden, Arps, Slate, Meagher & Flom (New York)

Clifford H. Aronson

Skadden, Arps, Slate, Meagher & Flom (New York)
Partner

Clifford H. Aronson is a partner with Skadden in New York. He focuses his practice on advising clients in antitrust matters relating to mergers and acquisitions. He has been involved in numerous high-profile transactions and strategic alliances across multiple industries, including entertainment, consumer products, health care, manufacturing, pharmaceutical, retail and technology. Mr. Aronson repeatedly has been selected for inclusion in Chambers USA: America’s Leading Lawyers for Business and The Best Lawyers in America.

Distinctions

Linked authors

Skadden, Arps, Slate, Meagher & Flom (London)
Skadden, Arps, Slate, Meagher & Flom (London)
Skadden, Arps, Slate, Meagher & Flom (London)
Skadden, Arps, Slate, Meagher & Flom (Brussels)
Skadden, Arps, Slate, Meagher & Flom (Washington)

Articles

9004 Bulletin

Steven C. Sunshine, Boris Bershteyn, Kenneth Schwartz, David Wales, Matthew Martino, Julia K. York, Karen M. Lent, Michael H. Menitove, Michael Sheerin, Tara L. Reinhart, Joseph M. Rancour, Clifford H. Aronson, Maria Raptis The US FTC and DOJ introduce the new merger guidelines which are designed to modernize the US merger enforcement

56

The Federal Trade Commission (FTC) and Antitrust Division of the Department of Justice (DOJ) released a draft of proposed new merger guidelines today, 18 months after FTC Chair Lina Khan and Assistant Attorney General Jonathan Kanter announced plans to “modernize” the agencies’ approach to (...)

Karen M. Lent, Giorgio Motta, Tara L. Reinhart, Clifford H. Aronson, Steven C. Sunshine, David Wales The US DoJ publishes a statement cautioning that the antitrust laws remain in effect and agreements among competitors that set commercial terms may be illegal

176

Antitrust-Related Considerations Collaborations With Competitors Companies seeking to collaborate with competitors in response to the COVID-19 crisis must keep in mind, as the Department of Justice has recently cautioned, that the antitrust laws remain in effect, and agreements among (...)

Clifford H. Aronson, Kenneth Schwartz, Maria Raptis, Matthew P. Hendrickson, Steven C. Sunshine The US District Court for the District of Columbia blocks two proposed mergers in the insurance sector brought and litigated under the Obama administration (Aetna / Humana and Anthem / Cigna)

202

In a continuation of recent Department of Justice (DOJ) successes challenging mergers, the U.S. District Court for the District of Columbia recently enjoined two more proposed mergers brought and litigated under the Obama administration. Aetna’s $37 billion proposed acquisition of Humana was (...)

Clifford H. Aronson, Maria Raptis, Matthew P. Hendrickson The US District Court for the District of Columbia grants the Federal Trade Commission’s request for a preliminary injunction halting a merger in the office supply superstores sector (Staples / Office Depot)

535

On May 10, 2016, Judge Emmet G. Sullivan of the U.S. District Court for the District of Columbia released his highly anticipated decision in the matter of Staples’ acquisition of Office Depot, granting the Federal Trade Commission’s (FTC) request for a preliminary injunction and effectively (...)

Clifford H. Aronson, Kenneth Schwartz, Matthew P. Hendrickson The US DoJ files a complaint against an activist investor before the US District Court for the Northern District of California for violations of the Hart-Scott-Rodino Act (ValueAct)

4129

On April 4, 2016, the U.S. Department of Justice, Antitrust Division (DOJ) led
 a complaint against activist investor ValueAct Capital in California federal court, requesting a $19 million fine for violations of the Hart-Scott-Rodino (HSR) Act’s notifcation provisions . The DOJ’s complaint (...)

Clifford H. Aronson, John H. Lyons, Matthew P. Hendrickson The U.S. District Court for the Northern District of Ohio denies the FTC’s bid to prevent company from acquiring its alleged potential competitor (Steris / Synergy Health)

202

On September 24, 2015, the U.S. District Court for the Northern District of Ohio denied the Federal Trade Commission’s (FTC) bid to enjoin Steris Corporation (Steris) from acquiring its alleged potential competitor, Synergy Health plc (Synergy). The loss breaks a string of victories in merger (...)

Clifford H. Aronson, John H. Lyons, Kenneth Schwartz, Maria Raptis, Matthew P. Hendrickson, Steven C. Sunshine The US District Court for the Northern District of Ohio denies the Federal Trade Commission’s bid to enjoin a company from acquiring its alleged potential competitor (Steris / Synergy)

212

This article has been nominated for the 2016 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On September 24, 2015, the U.S. District Court for the Northern District of Ohio denied the Federal Trade Commission’s (FTC) bid to enjoin Steris Corporation (...)

Clifford H. Aronson, Kenneth Schwartz, Matthew P. Hendrickson The DoJ condemns pre-merger coordination requiring target company to sell factory (Flakeboard America / SierraPine)

344

On November 7, 2014, the United States Department of Justice, Antitrust Division (DOJ) announced a $5 million agreement to settle charges that Flakeboard and SierraPine had engaged in unlawful pre-merger coordination . The DOJ’s complaint alleged that the parties’ conduct constituted both a (...)

Clifford H. Aronson, Sharis A. Pozen, Steven C. Sunshine The US Court of Appeals for the Sixth Circuit confirms the decision of the FTC regarding a merger in the healthcare sector (ProMedica)

256

On April 22, 2014, the United States Court of Appeals for the Sixth Circuit handed the Federal Trade Commission (FTC or Commission) another significant victory in a hospital merger, ruling that the FTC’s decision and order requiring that ProMedica divest St. Luke’s, another Lucas County, (...)

Alec Y. Chang, Clifford H. Aronson, Joanna Warren, Sharis A. Pozen The US Supreme Court narrows "State-Action" doctrine in hospital merger challenged by the US FTC (Phoebe Putney)

358

In a unanimous decision issued on February 19, 2013, the U.S. Supreme Court ruled that the state-action doctrine did not immunize Phoebe Putney Health System’s acquisition of Palmyra Park Hospital in Albany, Georgia. The decision immediately was hailed by FTC Chairman Jon Leibowitz as "a big (...)

Alec Y. Chang, Clifford H. Aronson, Ian G. John, James A. Keyte The US District Court for the District of Columbia grants DoJ request to enjoin a merger between two digital do-it-yourself tax preparation software providers (H&R Block / TaxAct)

753

This article has been nominated for the 2012 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On October 31, 2011, the U.S. District Court for the District of Columbia is sued an order enjoining H&R Block, Inc.’s acquisition of a rival tax (...)

Alec Y. Chang, Clifford H. Aronson, Ian G. John, Neal R. Stoll The US District Court for the Central District of California denies the FTC’s request for a preliminary injunction in a medical laboratory merger case (LabCorp / Westcliff)

220

In a decision broadly critical of the Federal Trade Commission’s case challenging the acquisition of Westcliff Medical Laboratories, Inc., a medical laboratory company, by Laboratory Corporation of America (LabCorp), Judge Andrew Guilford of the U.S. District Court for the Central District of (...)

Clifford H. Aronson, Matthew P. Hendrickson, Steven C. Sunshine The US Court of Appeals for the DC Circuit reverses the denial of a preliminary injunction sought by an undertaking against a merger in the organic food sector (Whole Foods / Wild Oats)

383

On July 29, 2008, the U.S. Court of Appeals for the D.C. Circuit reversed the denial of a preliminary injunction sought by the FTC against a merger of Whole Foods Market, Inc. and Wild Oats Markets, Inc., in a ruling that significantly lowers the bar for the FTC to obtain preliminary (...)

Clifford H. Aronson, Steven C. Sunshine The US FTC dismisses merger challenge after parties publicly announced to abandon the proposed acquisition in the healthcare industry (Inova / PWHS)

221

Inova Health System Foundation (Inova) and Prince William Health System, Inc. (PWHS) announced today that they will abandon their proposed merger. This announcement comes after the Federal Trade Commission sought to preliminarily enjoin the merger so that it could conduct a “Fast Track” (...)

Statistics


9004
Total visits

500.2
Number of readings per contribution

18
Number of contributions

Author's ranking
543th
In number of contributions
1094th
In number of visits
4046th
In average number of visits
Send a message